Faron Pharmaceuticals Oy (DI) (FARN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 182.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 262.50
  • 52 Week Low: 150.00
  • Currency: UK Pounds
  • Shares Issued: 114.42m
  • Volume: 264
  • Market Cap: £208.82m

Faron strengthens bexmarilimab potential with fresh trial data

By Josh White

Date: Monday 20 Oct 2025

LONDON (ShareCast) - (Sharecast News) - Faron Pharmaceuticals said on Monday that updated results from its phase one and two 'BEXMAB' study showed further improvement in the clinical performance of bexmarilimab, strengthening the drug's profile as a treatment for newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS).
The AIM-traded firm said the data, presented at the European Society for Medical Oncology (ESMO) Congress 2025 by Dr Mika Kontro of Helsinki University Hospital, confirmed an 85% objective response rate and a 45% complete remission rate among 20 evaluable treatment-naïve patients treated with bexmarilimab in combination with azacitidine.

It said 55% of those patients showed full clearance of bone marrow blasts, while those with lower baseline blast counts (

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

FARN Market Data

Currency UK Pounds
Share Price 182.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 262.50
52 Week Low 150.00
Volume 264
Shares Issued 114.42m
Market Cap £208.82m

FARN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
41.46% below the sector average41.46% below the sector average41.46% below the sector average41.46% below the sector average41.46% below the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 0
Sell 0
Strong Sell 1
Total 5
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

FARN Dividends

No dividends found

Trades for 05-Dec-2025

Time Volume / Share Price
13:18 259 @ 183.00p
12:09 3 @ 190.00p
12:09 2 @ 190.00p

FARN Key Personnel

CEO Juho Jalkanen
Chair Tuomo Pätsi
CFO Jurriaan Dekkers

Top of Page